“Carcinoma de pulmón célula no pequeña: ¿hay diferencias por histología utilizando inmunoterapia?” - page 13

Beyond the histology
PD-L1/other
immune
biomarkers
What factors may
impact outcomes with immune
checkpoint inhibitors?
Mutational
status Histology
Patient
characteristics